SCRI-Oncology Partners — Nashville, Tennessee

SCRI-Oncology Partners is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

SCRI-Oncology Partners has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Breast Cancer Stage III, HER2-positive Metastatic Breast Cancer, Unresectable Breast Carcinoma.

Sponsors: SystImmune Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SCRI-Oncology Partners?

SCRI-Oncology Partners has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SCRI-Oncology Partners conducted?

SCRI-Oncology Partners has 1 clinical trials on record, with 1 currently active. Their work covers Breast Cancer Stage III, HER2-positive Metastatic Breast Cancer, Unresectable Breast Carcinoma.

Is SCRI-Oncology Partners accredited by Crixeo Health?

SCRI-Oncology Partners has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SCRI-Oncology Partners?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.